Skip to main content
. 2020 Jul 28;17(15):5408. doi: 10.3390/ijerph17155408

Table 4.

Weighted geometric means (GMs, ng/mL) comparisons of six selected VOCMs in the PATH Study Wave 1 and the National Health and Nutrition Examination Survey (NHANES) 2015–2016 data stratified by smokers and never users.

Variable Smokers Never Users
NHANES
2015–2016
PATH Study
Wave 1
2013–2014
p-Value NHANES
2015–2016
PATH Study Wave 1
2013–2014
p-Value
n GM
(SE)
n GM
(SE)
n GM
(SE)
n GM
(SE)
t4HBEMA 888 15.7
(1.32)
8080 18.9
(0.444)
0.0208 1331 3.54
(0.15)
3153 4.28
(0.081)
<0.0001
3HPMA 842 725
(39.7)
7973 841
(14.9)
0.0064 1239 221
(7.12)
3153 255
(5.78)
0.0002
2COEMA 888 178
(10.1)
7637 218
(3.17)
0.0001 1331 91.8
(3.03)
3022 92.2
(1.77)
0.9070
2CYEMA 888 58.0
(6.76)
7637 68.4
(2.66)
0.1511 1331 1.41
(0.09)
3022 1.25
(0.034)
0.0967
3HMPMA 888 1.28 × 103
(79.6)
8081 1.62 × 103
(37.1)
0.0001 1331 378
(12.80)
3153 433
(10.2)
0.0009
4HMBEMA 888 18.1
(1.74)
8057 21.4
(0.637)
0.0732 1331 3.22
(0.09)
3120 3.14
(0.088)
0.5241

SE: Standard error; t4HBEMA: N-acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine; 3HPMA: N-acetyl-S-(3-hydroxypropyl)-L-cysteine; 2COEMA: N-acetyl-S-(2-carboxyethyl)-L-cysteine; 2CYEMA: N-acetyl-S-(2-cyanoethyl)-L-cysteine; 3HMPMA: N-acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine; 4HMBEMA: N-acetyl-S-(4-hydroxy-2-methyl-2-buten-1-yl)-L-cysteine.